Saturday, October 31, 2026

American Water Works Company, Inc. And 4 Other Stocks Have Very High Payout Ratio

ViaNews Editorial Team

December 24, 2020

American Water Works Company, Inc. And 4 Other Stocks Have Very High Payout Ratio

We have collected information concerning stocks with the highest payout ratio as yet. The payout ratio in itself isn't a assurance of good investment but it's an indicator of whether dividends are being paid and how the company chooses to issue them.

When investigating a potential investment, the dividend payout ratio is a good statistic to know and anything around 60 percent is considered high.

1. The Blackstone Group L.P.

163.16% Payout Ratio

The Blackstone Group Inc. is an alternative asset management firm specializing in real estate, private equity, hedge fund solutions, credit, secondary funds of funds, public debt and equity and multi-asset class strategies.

According to Morningstar, Inc., the next dividend payment is on Nov 5, 2020, the estimated forward annual dividend rate is 1.91 and the estimated forward annual dividend yield is 2.96%.

The Blackstone Group L.P.'s sales growth this year is expected to be 1.1% and 27.5% for next year.

Year-on-year quarterly revenue growth grew by 100.5%, now sitting on 4.58B for the twelve trailing months.

The Blackstone Group L.P.'s sales growth is 23.6% for the present ongoing quarter and 45.2% for the next. The company's growth estimates for the ongoing quarter and the next is 16.7% and 43.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.14%.

The Blackstone Group L.P.'s Stock Yearly Top and Bottom Value

The Blackstone Group L.P.'s stock is valued at $64.60 at 01:23 EST, under its 52-week high of $65.75 and way above its 52-week low of $33.00.

The Blackstone Group L.P.'s Moving Average

The Blackstone Group L.P.'s value is higher than its 50-day moving average of $59.23 and way above its 200-day moving average of $55.58.

2. Enersys

30.97% Payout Ratio

EnerSys manufactures, markets, and distributes industrial batteries.

According to Morningstar, Inc., the next dividend payment is on Dec 16, 2020, the estimated forward annual dividend rate is 0.7 and the estimated forward annual dividend yield is 0.84%.

Enersys's sales growth this year is expected to be negative 3.7% and 6.4% for next year.

Year-on-year quarterly revenue growth declined by 7.1%, now sitting on 2.96B for the twelve trailing months.

Enersys's sales growth for the next quarter is 2.4%. The company's growth estimates for the ongoing quarter and the next is 14.4% and 18%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.02%.

Enersys's Stock Yearly Top and Bottom Value

Enersys's stock is valued at $83.62 at 01:23 EST, under its 52-week high of $86.87 and way higher than its 52-week low of $35.21.

Enersys's Moving Average

Enersys's worth is higher than its 50-day moving average of $81.23 and way above its 200-day moving average of $71.90.

3. Cambridge Bancorp

46.56% Payout Ratio

Cambridge Bancorp operates as the bank holding company for Cambridge Trust Company that provides commercial and consumer banking, and investment management and trust services.

As claimed by Morningstar, Inc., the next dividend payment is on Nov 3, 2020, the estimated forward annual dividend rate is 2.12 and the estimated forward annual dividend yield is 2.91%.

Cambridge Bancorp's sales growth this year is expected to be 38.8% and 8.7% for next year.

Year-on-year quarterly revenue growth grew by 50.1%, now sitting on 127.65M for the twelve trailing months.

Cambridge Bancorp's sales growth is 42.3% for the present current quarter and 48.1% for the next. The company's growth estimates for the ongoing quarter and the next is 21.5% and 26.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.19%.

Cambridge Bancorp's Stock Yearly Top and Bottom Value

Cambridge Bancorp's stock is valued at $70.67 at 01:23 EST, way under its 52-week high of $81.02 and way higher than its 52-week low of $44.20.

Cambridge Bancorp's Moving Average

Cambridge Bancorp's worth is higher than its 50-day moving average of $68.20 and way higher than its 200-day moving average of $58.75.

4. American Water Works Company, Inc.

57.53% Payout Ratio

American Water Works Company, Inc., through its subsidiaries, provides water and wastewater services in the United States.

As claimed by Morningstar, Inc., the next dividend payment is on Feb 4, 2021, the estimated forward annual dividend rate is 2.2 and the estimated forward annual dividend yield is 1.46%.

American Water Works Company, Inc.'s sales growth this year is expected to be 5.5% and 4.9% for next year.

Year-on-year quarterly revenue growth grew by 6.5%, now sitting on 3.76B for the twelve trailing months.

American Water Works Company, Inc.'s sales growth is 5% for the ongoing current quarter and 5.3% for the next. The company's growth estimates for the ongoing quarter and the next is 11% and 9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.42%.

American Water Works Company, Inc.'s Stock Yearly Top and Bottom Value

American Water Works Company, Inc.'s stock is valued at $150.24 at 01:23 EST, way under its 52-week high of $172.56 and way above its 52-week low of $92.00.

American Water Works Company, Inc.'s Moving Average

American Water Works Company, Inc.'s value is below its 50-day moving average of $154.93 and above its 200-day moving average of $144.81.

5. First Interstate BancSystem, Inc.

51.55% Payout Ratio

First Interstate BancSystem, Inc. operates as the bank holding company for First Interstate Bank that provides range of banking products and services in the United States.

As maintained by Morningstar, Inc., the next dividend payment is on Nov 4, 2020, the estimated forward annual dividend rate is 1.52 and the estimated forward annual dividend yield is 3.83%.

First Interstate BancSystem, Inc.'s sales growth this year is anticipated to be 2.6% and a negative 4.5% for next year.

Year-on-year quarterly revenue growth grew by 1.7%, now sitting on 614.3M for the twelve trailing months.

First Interstate BancSystem, Inc.'s sales growth is 1% for the ongoing present quarter and 0.1% for the next. The company's growth estimates for the next quarter is 60%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.42%.

First Interstate BancSystem, Inc.'s Stock Yearly Top and Bottom Value

First Interstate BancSystem, Inc.'s stock is valued at $39.74 at 01:23 EST, below its 52-week high of $42.53 and way above its 52-week low of $24.50.

First Interstate BancSystem, Inc.'s Moving Average

First Interstate BancSystem, Inc.'s worth is higher than its 50-day moving average of $38.98 and way above its 200-day moving average of $33.80.

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com